P

Prof. Dr. Roger Nitsch

Advisory Board
๐Ÿ’ผ Partner at Pureos Bioventures โ†’
About

Co-founder, CEO and President of Neurimmune. Key opinion leader in neurodegenerative diseases. Pioneer in therapeutic approaches for neurodegenerative diseases; inventor and developer of aducanumab in partnership with Biogen, first disease-modifying treatment and first approved therapy in over two decades for Alzheimer disease. Professor emeritus at Institute for Regenerative Medicine, University of Zurich. Potamkin prize winner; member of German Academy of Sciences. MD from University of Heidelberg.

Focus Areas

Diagnostics, Biopharma, Biotech, Life Sciences

Location

๐Ÿ“ Based in Zurich, Switzerland

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account ยท Get started in 1-click